Pfizer and BioNTech claim that the newly discovered Covid-19 vaccine found to be more than 90% effective. These two vaccine manufacturer companies demanded 90% protection from Covid-19.
Since the beginning of the Covid-19 epidemic, Pfizer and BioNTech have been trying to develop vaccines, at this time two companies said their vaccine is up to 90% effective.
According to the BBC, the newly developed vaccine was administered to about 43,500 people in six countries. No one had an adverse reaction after the vaccination. “This is an important day for science and humanity,” Pfizer and BioNTech said in a statement.
US pharmaceutical companies Pfizer and BioNTech said they would apply for urgent approval of the vaccine later this month.
Earlier, Pfizer said they would know the results of the corona vaccine by October. The company later said that the results of their vaccination could be known within this year. The results of the vaccine finally came in November.
According to the company, a preliminary analysis of the vaccine has confirmed 90% effectiveness.
Pfizer had previously said that if the vaccine test went well and the vaccine was approved, the company would be able to supply 40 million doses of vaccine in the United States. It was said that an application for emergency approval of the vaccine was being considered in the third week of November.
Work began on a number of vaccines around the world for the coronavirus epidemic. According to the World Health Organization, more than 150 vaccines are now being developed around the world.
Of these, 44 ticker clinical trials are underway. already 11 vaccines are in the final stages of testing. Pfizer and Bioentech were among the first vaccines to be tested in the third phase.
The Pfizer and BioNTech vaccines have been tested experimentally in the United States, Germany, Brazil, Argentina, South Africa and Turkey. It found that seven days after the second dose of the vaccine was applied, the vaccine provided up to 90% protection against Covid-19.
In this case, two doses of the vaccine had to be given at intervals of three weeks.
Pfizer said it would be able to deliver 50 million doses of the vaccine by the end of this year. And by the end of 2021, it will be able to supply 1.3 billion doses of vaccine.
“We are well on our way to helping people around the world to end the global health crisis,” said Albert Bourla, Pfizer’s chief executive officer (CEO). Professor Ur Sahin, one of the founders of BioNTech, called the achievement a “milestone”.
However, the BBC reports that the data presented is not for the final analysis. The calculations were based on tests on the first 94 volunteers infected with Covid-19. This data may change slightly after the full results have been analyzed.